Biotech Essentials

Companies & Industries

Biotech Companies & Industries Essentials publishes only the best Biotech news and links, carefully hand-picked and curated by top biotech experts.

Top news of the week: 29.04.2021.

#biotechnology
#lifesciences
#pharmaceuticals
#COVID19
#pandemic
#AtopicDermatitis

Companies And Industries

@biospace shared
On Apr 23, 2021
@Ocugen on track to bring @BharatBiotech's COVAXIN to US market with strong data #lifesciences #biotechnology #pharmaceuticals https://t.co/C5eL9kPZ7p
Open
Ocugen On Track to Bring Bharat Biotech's COVAXIN to US Market With Strong Data

Ocugen On Track to Bring Bharat Biotech's COVAXIN to US Market With Strong Data

Ocugen’s plan to bring a COVID-19 vaccine developed by India-based Bharat Biotech later this year remains on track following an interim analysis of Phase III data that shows the vaccine ...

@biospace shared
On Apr 27, 2021
2021 COVID-19 News: COVID-19 possible spread in vehicles, US to share AZ's COVID-19 vaccine globally, and more #pandemic #COVID19 https://t.co/gn7T1wCZaG
Open
2021 COVID-19 News: COVID-19 Possible Spread in Vehicles, US to Share AZ's COVID-19 Vaccine Globally, and More

2021 COVID-19 News: COVID-19 Possible Spread in Vehicles, US to Share AZ's COVID-19 Vaccine Globally, and More

Please check out the biopharma industry's COVID-19 stories that are trending for April 27, 2021.

@BIRAC_2012 shared
On Apr 26, 2021
“Besides the 3 vaccines approved for Emergency Use Authorization, there is a promising pipeline of four-five candidates in advanced clinical stages of development."-Secretary @DBTIndia @RenuSwarup https://t.co/cTpRAK6tAZ
Open
Single dose Bharat Biotech intranasal vaccine in advanced stages of clinical trials: DBT Secretary

Single dose Bharat Biotech intranasal vaccine in advanced stages of clinical trials: DBT Secretary

​​Efforts are being ramped up for massive production of COVID-19 vaccines and make them available in the shortest possible time, the DBT Secretary said, stressing that India currently has a ...

@SanofiGenzyme shared
On Apr 26, 2021
Our research with @Regeneron focuses on finding insights to support long-term care for people living with #AtopicDermatitis (AD). Learn more: https://t.co/voPi7pdBCj https://t.co/jy22HuOMM1
Open
Immunology and Inflammation R&D

Immunology and Inflammation R&D

Sanofi researchers aim to rebalance immune and inflammatory responses that drive systemic, chronic diseases.

@biospace shared
On Apr 24, 2021
CEO salaries for the top 20 pharma companies by market cap https://t.co/rUtTInBHUc
Open
CEO Salaries for the Top 20 Pharma Companies by Market Cap

CEO Salaries for the Top 20 Pharma Companies by Market Cap

Executives at pharmaceutical companies are known for receiving large salaries. When bonuses and stock options are factored into the picture, their annual compensation can jump into the ...

@FierceBiotech shared
On Apr 27, 2021
Cancer-related assets accounted for more than half (eight) of the top 15, with four in the cancer immunotherapy area, demonstrating that biopharma's appetite for this area is far from sated https://t.co/syYiGJAd0m
Open
The top 15 biopharma licensing deals of 2020

The top 15 biopharma licensing deals of 2020

Oncology, specifically immuno-oncology, was the dominant theme in biopharma licensing last year, as cancer drugs accounted for half of the top deals.

@GENbio shared
On Apr 28, 2021
GEN Edge Latest: GEN Edge spoke with Robert Hariri, MD, PhD, the chairperson, founder, and CEO of @celularity to discuss the company’s 20-year journey from inception to Celgene spinoff and, recently, a SPAC-funded, publicly traded entity. Learn more: https://t.co/iya2AWGWd1 https://t.co/3sCu2kqLLj
Open
Celularity: Productizing Placental-Derived Stem Cells for Any Patient

Celularity: Productizing Placental-Derived Stem Cells for Any Patient

GEN Edge spoke with Robert Hariri, MD, PhD, the chairperson, founder, and CEO of Celularity, to discuss the company’s 20-year journey from inception to Celgene spinoff and, recently, a ...

@FierceBiotech shared
On Apr 27, 2021
GV is tasking Lynch with helping the CEOs and executives of its portfolio companies as a coach, mentor and adviser, as well as with identifying new investments and participating in decisions about which biotechs to back https://t.co/h23nw2VSy9
Open
GV hires industry veteran Lynch to coach biotech CEOs, identify new investments

GV hires industry veteran Lynch to coach biotech CEOs, identify new investments

GV has hired serial biotech chairman Dan Lynch as its first executive venture partner. The appointment positions Lynch to serve as a coach and adviser to executives at GV’s portfolio ...